SynCo Bio Partners BV Company Profile

05:27 EDT 23rd September 2017 | BioPortfolio

SynCo Bio Partners B.V. is an ultramodern, private company (a former production facility of Chiron) based in Amsterdam, The Netherlands. The company boasts over 10 years of experience in process development and manufacture of biologics. Its workforce is made up of highly skilled personnel and now totals 45 employees. SynCo's mission is to facilitate commercialization of biomolecular research, by developing cost-effective and scaleable manufacturing processes, all through state-of-the-art technology. SynCo's Biotechnology Center accomodates a fully equipped and cGMP licensed plant, including laboratories for advanced analytical and process development, separate suites for small and large scale fermentation, purification and aseptic filling, facilities for freeze-drying and for labeling and packaging. As such, it is ideally suited for taking a product through initial development stages, from process design up to and including manufacture of product for use in clinical trials. Clients may choose from SynCo's broad array of services in accordance with specific needs e.g. supply of formulated lyophilized product for clinical studies only. In-house expertise is available for effective regulatory guidance, both on pharmaceutical and clinical issues. Production is currently based on bacteriall cell systems, but expansion into mammalian cell technology is being realised. To be able to offer the broadest possible biopharmaceutical services, SynCo has entered into a number of partnerships with highly specialized organisations e.g. Amersham Pharmacia Biotech. Thus, clients will not need to seek additional resources themselves - a real one-stop-shopping concept.


Paasheuvelweg 30
NL-1105 BJ


Phone: +31 20 750 3600
Fax: +31 20 750 3601

News Articles [249 Associated News Articles listed on BioPortfolio]

Managing post-amputation pain with neurostimulation, Neuros Medical raises $20M

U.S. Venture Partners led the round with participation from Boston Scientific, Aperture Venture Partners, Osage University Partners, and JumpStart.

Genoa closes $62mm Series A

Pulmonary disease-focused Genoa Pharmaceuticals Inc. raised $62mm through its Series A financing led by F-Prime Capital Partners and Edmond de Rothschild Investment Partners, which were joined by Novo...

Deals this week: Vertos Medical, Kiadis Pharma, Oxis International

Vertos Medical has closed a venture financing to raise $28m from MVM Life Science Partners, Leerink Revelation Partners, Pitango Venture Capital, ONSET Ventures and Aweida Venture Partners.

MorphoSys-Aktie: Shortseller AHL Partners zieht sich wieder stark zurück - Aktiennews

Martinsried - Leerverkäufer AHL Partners LLP baut Netto-Leerverkaufsposition in MorphoSys-Aktien wieder signifikant ab: Die Leerverkäufer von AHL Partners LLP haben ihr Short-Engagement in den Akti....

Evotec-Aktie bleibt unter Beschuss von Leerverkäufer AHL Partners! Aktiennews

Hamburg - Leerverkäufer AHL Partners LLP stockt Netto-Leerverkaufsposition in Aktien der Evotec AG weiter sichtbar auf: Die Leerverkäufer von AHL Partners LLP befinden sich kontinuierlich im Attack....

Is it sometimes ok to cheat?

(Smithsonian Tropical Research Institute) When both partners benefit from a relationship -- husband and wife or pollinator and flower -- the relationship is known as a mutualism. Sometimes partners do...

Is it sometimes OK to cheat? Wasps that do not pollinate figs may flourish when they go unpunished

When both partners benefit from a relationship—be they husband and wife or pollinator and flower—the relationship is known as a mutualism. But sometimes partners do not deliver their side of the b...

Mandel-Brehm to join Polaris Partners

Polaris Partners, a venture capital investor in technology and healthcare, announced that Josh Mandel-Brehm will join the firm as an entrepreneur-in-residence. Mandel-Brehm previously held various pos...

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Sweatblock [DC Alpine Partners, LLC DBA: Sweatblock]

SWEATBLOCK Clinical Strength Antiperspirant

Day cream mattifying hydrator [MOSAIC MARKETING PARTNERS LLC]


Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

PubMed Articles [278 Associated PubMed Articles listed on BioPortfolio]

A qualitative study of secondary distribution of HIV self-test kits by female sex workers in Kenya.

Promoting awareness of serostatus and frequent HIV testing is especially important among high risk populations such as female sex workers (FSW) and their sexual partners. HIV self-testing is an approa...

Male engagement in women's microbicide use in Kenya: Navigating gender norms.

The success of women's microbicide use for HIV/AIDS prevention may hinge on health programs' ability to engage men to support it. In this qualitative study in Kenya, most women did not or would not te...

Lessons Learned from Participatory Design in Dementia Care: Placing Care Partners at the Centre.

In this paper we analyze the participatory design (PD) process of a health information technology (HIT) project. This project, AToM was situated in dementia care and involved partners from academia, i...

Psychological distress in men with prostate cancer and their partners before and after cancer diagnosis: a longitudinal study.

To examine the relative risk of psychological distress of men with prostate cancer and their partners during the period before and after prostate cancer diagnosis compared with men without prostate ca...

Partners of nulliparous women with severe fear of childbirth: A longitudinal study of psychological well-being.

Little is known about the psychological status of partners of women with severe fear of childbirth (FOC). In this longitudinal study from Helsinki University Central Hospital, we investigated FOC, dep...

Clinical Trials [235 Associated Clinical Trials listed on BioPortfolio]

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

This pilot clinical trial studies how well acceptance and commitment therapy works in improving well-being in patients with stage III-IV cancer and their partners. Learning how to accept n...

Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners

RATIONALE: Participating in a therapy program may enhance communication and intimacy between men with prostate cancer and their partners. PURPOSE: This randomized clinical trial is studyi...

A Case Control Study of Women With Multiple Sexual Partners

Both population based surveys and more focused research studies indicate that increased numbers of sexual partners and partner concurrency contribute to increased risk for acquisition of s...

Companies [880 Associated Companies listed on BioPortfolio]

SynCo Bio Partners

SynCo Bio Partners is a GMP-licensed bulk drug substance and final product CMO with clinical and commercial production experience in mammalian and microbial systems. This experience has been acqui...

SynCo Bio Partners BV

SynCo Bio Partners B.V. is an ultramodern, private company (a former production facility of Chiron) based in Amsterdam, The Netherlands. The company boasts over 10 years of experience in process devel...

SynCo Bio Partners B.V.

The history of SynCo is one of growth, change and extensive experience in the development and manufacture of Biopharmaceuticals. The Amsterdam facility has been manufacturing commerical product since ...

SageCreek Partners

SageCreek Partners is creating and driving a new category of service: Mentor Capital. Working as a companion to technology companies and their investment partners and boards, Sage...

Health Partners Plans (HPP)

Nationally recognized for its innovations in managed care, Health Partners Plans consistently receives the highest ratings for member and provider satisfaction and, is currently r...

More Information about "SynCo Bio Partners BV" on BioPortfolio

We have published hundreds of SynCo Bio Partners BV news stories on BioPortfolio along with dozens of SynCo Bio Partners BV Clinical Trials and PubMed Articles about SynCo Bio Partners BV for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SynCo Bio Partners BV Companies in our database. You can also find out about relevant SynCo Bio Partners BV Drugs and Medications on this site too.

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Corporate Database Quicklinks

Searches Linking to this Company Record